Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIM
3301
AIM ImmunoTech
AIM
$6.54M
| $9K | ﹤0.01% |
6
-6
| -50% | -$8.63K |
|
3302
InspireMD
NSPR
$32.1M
| $8K | ﹤0.01% |
+2
| New | +$16.6K |
|
3303
Atossa Therapeutics
ATOS
$24.1M
| $3K | ﹤0.01% |
60
-1,804
| -97% | -$131K |
|
3304
Oragenics
OGEN
$2.24M
| $3K | ﹤0.01% |
+1
| New | +$6.29K |
|
3305
AbbVie
ABBV
$465B
| – | – |
-1,407,856
| Closed | -$125M |
|
3306
Asbury Automotive
ABG
$4.49B
| – | – |
-20,904
| Closed | -$1.28M |
|
3307
ADMA Biologics
ADMA
$2.04B
| – | – |
-20,300
| Closed | -$63K |
|
3308
Autodesk
ADSK
$50.1B
| – | – |
-867,768
| Closed | -$97.4M |
|
3309
Aflac
AFL
$65.9B
| – | – |
-1,049,000
| Closed | -$42.7M |
|
3310
American International
AIG
$42.9B
| – | – |
-2,324,260
| Closed | -$143M |
|
3311
AAR Corp
AIR
$5.62B
| – | – |
-108,660
| Closed | -$4.11M |
|
|
AL
3312
DELISTED
Air Lease Corp
AL
| – | – |
-30,200
| Closed | -$1.29M |
|
3313
Alaska Air
ALK
$5.42B
| – | – |
-334,000
| Closed | -$25.5M |
|
3314
Alto Ingredients
ALTO
$345M
| – | – |
-135,300
| Closed | -$751K |
|
3315
AMC Global Media
AMCX
$451M
| – | – |
-163,300
| Closed | -$9.55M |
|
3316
Ametek
AME
$55.3B
| – | – |
-57,550
| Closed | -$3.8M |
|
|
GOLD
3317
Gold.com Inc
GOLD
$1.18B
| – | – |
-33,400
| Closed | -$276K |
|
3318
AMERISAFE
AMSF
$573M
| – | – |
-13,700
| Closed | -$797K |
|
3319
A.O. Smith
AOS
$8.82B
| – | – |
-145,100
| Closed | -$8.62M |
|
3320
Apogee Enterprises
APOG
$873M
| – | – |
-33,683
| Closed | -$1.63M |
|
3321
ArcBest
ARCB
$3.33B
| – | – |
-13,700
| Closed | -$458K |
|
3322
Asure Software
ASUR
$237M
| – | – |
-165,876
| Closed | -$2.06M |
|
|
CVSA
3323
Covista Inc
CVSA
$4.3B
| – | – |
-180,400
| Closed | -$6.47M |
|
3324
ATI
ATI
$25.5B
| – | – |
-183,792
| Closed | -$4.39M |
|
3325
Avista
AVA
$3.46B
| – | – |
-177,500
| Closed | -$9.19M |
|
Similar funds
Renaissance Technologies's Q4 2017 Portfolio in Review
As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
- Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.